Litoxetine

DB15038InvestigationalSmall molecule

Litoxetine is under investigation in clinical trial NCT03397771 (DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence).

Chemical structure of Litoxetine
Formula / weight
C16H19NO · 241.334 g/mol (avg)

Resolves to

Compound
UNII9980ST005GCAS86811-09-8ChEMBLCHEMBL471036
Structure
InChIKeyMJJDYOLPMGIWND-UHFFFAOYSA-NSMILESC(OC1CCNCC1)C1=CC=C2C=CC=CC2=C1
Targets
P31645SLC6A4

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Litoxetine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In